Inhibition of NF-kappa B activity induces apoptosis in murine hepatocytes

Am J Pathol. 1997 Oct;151(4):891-6.

Abstract

Recently we have demonstrated that inhibition of the nuclear factor (NF)-kappa B/Rel family of transcription factors induces apoptosis of B cells. Interestingly, mice lacking the relA gene encoding the p65 subunit of NF-kappa B exhibit embryonic lethality at days 15 to 16 of gestation, accompanied by massive destruction of liver via apoptosis. To determine whether p65 protein plays a direct role in hepatocyte survival, we employed a nontransformed murine hepatocyte (NMH) cell line, which maintains to a high degree the differentiated hepatocyte phenotype. Exponentially growing NMH cells were found to possess a constitutive level of functional classical (p50/p65) NF-kappa B as assayed by electrophoretic mobility shift analysis, antibody supershift, and transient transfection assays. Treatment of NMH cells with the proteasome inhibitor lactacystin, which prevents degradation of the NF-kappa B inhibitor proteins I kappa B, induced apoptosis. Direct inhibition of the endogenous NF-kappa B activity by microinjection of NMH cells with purified specific inhibitor I kappa B-alpha-glutathione-S-transferase fusion protein or an antibody against p65 protein induced apoptosis. These findings suggest that expression of NF-kappa B/Rel activity in murine hepatocytes acts directly to promote survival of these cells and suggest that apoptosis observed in hepatocytes of mice lacking relA is a direct effect of p65 deficiency.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Acetylcysteine / analogs & derivatives
  • Acetylcysteine / pharmacology
  • Animals
  • Apoptosis* / physiology
  • Calcium-Binding Proteins*
  • Cell Line
  • Cysteine Proteinase Inhibitors / pharmacology
  • DNA Probes / chemistry
  • Glutathione Transferase / genetics
  • Glutathione Transferase / pharmacology
  • Liver / cytology
  • Liver / drug effects
  • Liver / physiology*
  • Membrane Glycoproteins / physiology
  • Mice
  • Microinjections
  • NF-kappa B / antagonists & inhibitors*
  • Nerve Tissue Proteins / physiology
  • Proto-Oncogene Proteins / genetics
  • Proto-Oncogene Proteins / pharmacology*
  • Recombinant Fusion Proteins / genetics
  • Recombinant Fusion Proteins / pharmacology
  • Synaptotagmin I
  • Synaptotagmins
  • Transcription Factor RelB
  • Transcription Factors*

Substances

  • Calcium-Binding Proteins
  • Cysteine Proteinase Inhibitors
  • DNA Probes
  • Membrane Glycoproteins
  • NF-kappa B
  • Nerve Tissue Proteins
  • Proto-Oncogene Proteins
  • Recombinant Fusion Proteins
  • Relb protein, mouse
  • Synaptotagmin I
  • Transcription Factors
  • lactacystin
  • Synaptotagmins
  • Transcription Factor RelB
  • Glutathione Transferase
  • Acetylcysteine